Home › Funds › Kintegral Advisory, LLC › BMY

Kintegral Advisory, LLC position in BMY

BRISTOL-MYERS SQUIBB CO · Health Care

Kintegral Advisory, LLC reported holding 116,771 shares of BMY (BRISTOL-MYERS SQUIBB CO) in its Q3 2026 13F filing — a position valued at US$7.3M, representing 0.57% of its reported portfolio and ranking #40 among its reported holdings. Kintegral Advisory, LLC has disclosed BMY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)116.77K sh
Reported value held$7.29M
Portfolio Weight0.57%
First reportedQ3 2023
Last changeAdd
Updated2026-10-17

Last updated: 2026-10-17 · Source: SEC EDGAR Form 13F-HR

How Kintegral Advisory, LLC's BMY position evolved

Kintegral Advisory, LLC first disclosed a stake in BMY in Q3 2023 at 78,866 shares (US$4.6M). The position peaked in Q1 2025 at 125,323 shares, worth US$7.6M. Across 13 filings, Kintegral Advisory, LLC increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 116,771 shares valued at US$7.3M — an increase of 660 shares quarter over quarter.. Notable position changes include a 71% increase in Q2 2024 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 78.87K $4.58M New
Q4 2023 78.37K $4.02M Reduce
Q1 2024 78.12K $4.24M Hold
Q2 2024 133.33K $5.54M Add
Q3 2024 131.60K $6.81M Reduce
Q4 2024 125.75K $7.11M Reduce
Q1 2025 125.32K $7.64M Hold
Q2 2025 125.14K $5.79M Hold
Q3 2025 124.58K $5.62M Hold
Q4 2025 121.26K $6.54M Reduce
Q1 2026 116.11K $7.04M Reduce
Q2 2026 116.11K $6.69M Hold
Q3 2026 116.77K $7.29M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMY and 13F data

BMY (BRISTOL-MYERS SQUIBB CO) is a Health Care company. 28 other funds we track also report a position in BMY — the largest reported positions include Banque Cantonale Vaudoise (US$7.85B), Charles Schwab Investment Management (US$3.89B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$3.89B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMY

All BMY fund holders →

FAQ

How long has Kintegral Advisory, LLC held BMY?

Kintegral Advisory, LLC has disclosed BMY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Kintegral Advisory, LLC's current position in BMY?

As of Q3 2026, Kintegral Advisory, LLC holds 116.77K shares of BMY (BRISTOL-MYERS SQUIBB CO), valued at $7.29M, representing 0.57% of its reported portfolio and ranking #40.

Has Kintegral Advisory, LLC been buying or selling BMY?

In the latest 13F filing (Q3 2026), Kintegral Advisory, LLC increased its position in BMY. The position peaked in Q1 2025 at 125.32K shares.

Which other funds hold BMY?

Other major institutional holders of BMY include Banque Cantonale Vaudoise, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.